cetirizine + placebo

Cetirizine + placebo refers to a combination used in clinical trials where one group receives cetirizine, an oral second-generation antihistamine, and the other group receives a placebo (an inactive substance). Cetirizine is primarily indicated for the relief of symptoms associated with allergic rhinitis (hay fever), perennial allergies, and chronic urticaria (hives). It works by selectively inhibiting peripheral histamine H1 receptors, thereby reducing allergy symptoms such as sneezing, itching, watery eyes, runny nose, and hives. Placebo is pharmacologically inactive and serves as a control in randomized controlled trials to assess the efficacy and safety of cetirizine compared to no active treatment[1][6]. This combination does not represent a marketed pharmaceutical product but rather describes an experimental setup commonly used in clinical research.

Brand names

Zyrtec

Other names

cetirizine hydrochloridecetirizine